These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 27662874)

  • 21. CIPHER: a flexible and extensive workflow platform for integrative next-generation sequencing data analysis and genomic regulatory element prediction.
    Guzman C; D'Orso I
    BMC Bioinformatics; 2017 Aug; 18(1):363. PubMed ID: 28789639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating Enhancer Function and Transcription.
    Field A; Adelman K
    Annu Rev Biochem; 2020 Jun; 89():213-234. PubMed ID: 32197056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging roles of transcriptional enhancers in chromatin looping and promoter-proximal pausing of RNA polymerase II.
    Meng H; Bartholomew B
    J Biol Chem; 2018 Sep; 293(36):13786-13794. PubMed ID: 29187597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HeRA: an atlas of enhancer RNAs across human tissues.
    Zhang Z; Hong W; Ruan H; Jing Y; Li S; Liu Y; Wang J; Li W; Diao L; Han L
    Nucleic Acids Res; 2021 Jan; 49(D1):D932-D938. PubMed ID: 33119754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global transcriptional activity dynamics reveal functional enhancer RNAs.
    Kim YJ; Xie P; Cao L; Zhang MQ; Kim TH
    Genome Res; 2018 Dec; 28(12):1799-1811. PubMed ID: 30352805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic transcriptional control of macrophage miRNA signature via inflammation responsive enhancers revealed using a combination of next generation sequencing-based approaches.
    Czimmerer Z; Horvath A; Daniel B; Nagy G; Cuaranta-Monroy I; Kiss M; Kolostyak Z; Poliska S; Steiner L; Giannakis N; Varga T; Nagy L
    Biochim Biophys Acta Gene Regul Mech; 2018 Jan; 1861(1):14-28. PubMed ID: 29133016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter-distal RNA polymerase II binding discriminates active from inactive CCAAT/ enhancer-binding protein beta binding sites.
    Savic D; Roberts BS; Carleton JB; Partridge EC; White MA; Cohen BA; Cooper GM; Gertz J; Myers RM
    Genome Res; 2015 Dec; 25(12):1791-800. PubMed ID: 26486725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of experimental assays and analytical methods for genome-wide identification of active enhancers.
    Yao L; Liang J; Ozer A; Leung AK; Lis JT; Yu H
    Nat Biotechnol; 2022 Jul; 40(7):1056-1065. PubMed ID: 35177836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.
    Franco HL; Nagari A; Malladi VS; Li W; Xi Y; Richardson D; Allton KL; Tanaka K; Li J; Murakami S; Keyomarsi K; Bedford MT; Shi X; Li W; Barton MC; Dent SYR; Kraus WL
    Genome Res; 2018 Feb; 28(2):159-170. PubMed ID: 29273624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancer RNA: biogenesis, function, and regulation.
    Ye R; Cao C; Xue Y
    Essays Biochem; 2020 Dec; 64(6):883-894. PubMed ID: 33034351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered enhancer transcription underlies Huntington's disease striatal transcriptional signature.
    Le Gras S; Keime C; Anthony A; Lotz C; De Longprez L; Brouillet E; Cassel JC; Boutillier AL; Merienne K
    Sci Rep; 2017 Feb; 7():42875. PubMed ID: 28225006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancer biology and enhanceropathies.
    Smith E; Shilatifard A
    Nat Struct Mol Biol; 2014 Mar; 21(3):210-9. PubMed ID: 24599251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-coding RNA derived from the region adjacent to the human HO-1 E2 enhancer selectively regulates HO-1 gene induction by modulating Pol II binding.
    Maruyama A; Mimura J; Itoh K
    Nucleic Acids Res; 2014 Dec; 42(22):13599-614. PubMed ID: 25404134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EnhancerAtlas 2.0: an updated resource with enhancer annotation in 586 tissue/cell types across nine species.
    Gao T; Qian J
    Nucleic Acids Res; 2020 Jan; 48(D1):D58-D64. PubMed ID: 31740966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in functional assays of transcriptional enhancers.
    Babbitt CC; Markstein M; Gray JM
    Genomics; 2015 Sep; 106(3):137-139. PubMed ID: 26100358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional control by enhancers and enhancer RNAs.
    Lewis MW; Li S; Franco HL
    Transcription; 2019; 10(4-5):171-186. PubMed ID: 31791217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intragenic Enhancers Attenuate Host Gene Expression.
    Cinghu S; Yang P; Kosak JP; Conway AE; Kumar D; Oldfield AJ; Adelman K; Jothi R
    Mol Cell; 2017 Oct; 68(1):104-117.e6. PubMed ID: 28985501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription.
    Rahman S; Zorca CE; Traboulsi T; Noutahi E; Krause MR; Mader S; Zenklusen D
    Nucleic Acids Res; 2017 Apr; 45(6):3017-3030. PubMed ID: 27932455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and Analysis of p53-Regulated Enhancers in Hepatic Carcinoma.
    Zhang Y; Qian M; Tang F; Huang Q; Wang W; Li Y; Li Z; Li B; Qiu Z; Yue J; Guo Z
    Front Bioeng Biotechnol; 2020; 8():668. PubMed ID: 32695760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancer RNAs stimulate Pol II pause release by harnessing multivalent interactions to NELF.
    Gorbovytska V; Kim SK; Kuybu F; Götze M; Um D; Kang K; Pittroff A; Brennecke T; Schneider LM; Leitner A; Kim TK; Kuhn CD
    Nat Commun; 2022 May; 13(1):2429. PubMed ID: 35508485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.